De-risk your inhaled drug development

Inhalation Sciences delivers exceptionally detailed insights early in development, empowering you to make confident, informed decisions.

An FDA-funded study shows that DissolvIt^® has the potential to generate data that can be used to predict clinical plasma profiles.

Why work with us?

• Gain rich, clinically relevant data earlier in development

• Reduce uncertainty and improve trial outcomes

• Advance with a proven platform for smarter and faster progress

Explore the PreciseInhale^® Technology Platform

• Download White Paper

• Download Premium Content on DissolvIt^® in vitro module

Ulf Wedenberg

Chief Commercial Officer